Litcius/Paper detail

Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)

Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, Ichinosuke Hyodo, Junki Mizusawa, Hiroki Hara, Tomohiro Nishina, Takeshi Sakamoto, Kohei Shitara, Katsunori Shinozaki, Hiroshi Katayama, Shinichiro Nakamura, Kei Muro, Masanori Terashima

2020Gastric Cancer50 citationsDOIOpen Access PDF

Topics & Concepts

MedicineFluorouracilPaclitaxelInternal medicineAbdominal surgerySurgical oncologyCancerOncologyChemotherapyGastroenterologyGastric Cancer Management and OutcomesIntraperitoneal and Appendiceal MalignanciesHelicobacter pylori-related gastroenterology studies
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G) | Litcius